Moreover, ninety percent of high-IL-13 producers had central obesity and hyperglycemia, while a similar amount also showed triglyceride levels higher than 200 mg/dl (data not shown), which suggests that increased IL-13 could concur with the development of metabolic syndrome. Here, IL13 is linked to metabolic syndrome.